Brief: Impact BioMedical Announces 1 For 12.62 Reverse Stock Split To Pursue Completion Of Merger With Zoar
11/09/2026 21:21
BRIEF-Impact BioMedical Announces 1 For 12.62 Reverse Stock Split To Pursue Completion Of Merger With Zoar Sept 11 (Reuters) - Impact Biomedical Inc IBO.A:
IMPACT BIOMEDICAL INC (NYSE AMERICAN: IBO) ANNOUNCES 1 FOR 12.62 REVERSE STOCK SPLIT TO PURSUE COMPLETION OF MERGER WITH ZOAR LTD. (PREVIOUSLY DR. ASHLEY’S LTD.)
IMPACT BIOMEDICAL - REVERSE STOCK SPLIT EFFECTIVE SEPTEMBER 23, 2026
Source text: ID:nGNX8Xsblj
Further company coverage: IBO.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Impact Biomedical
See all newsBrief: Impact BioMedical Announces 1 For 12.62 Reverse Stock Split To Pursue Completion Of Merger With Zoar
Brief: Impact Biomedical Says On July 21 Entered Debt Conversion Agreement With DSS
Brief: Dr Ashleys Limited And Impact Biomedical Inc. Announce Strategic Merger
Brief: Impact BioMedical Announces Issuance Of Canadian Patent For Linebacker Technology Targeting Inflammatory Disease
Brief: Impact Biomedical Inc. Announces Pricing Of Initial Public Offering